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Microparticles are membrane vesicles that are released during cell activation and
apoptosis. Elevated levels of microparticles occur in many cardiovascular diseases;
therefore, we characterized circulating microparticles from both metabolic syndrome
(MS) patients and healthy patients. We evaluated microparticle effects on
endothelial function; however, links between circulating microparticles and
endothelial dysfunction have not yet been demonstrated. Circulating microparticles
and their cellular origins were examined by flow cytometry of blood samples from
patients and healthy subjects. Microparticles were used either to treat human
endothelial cells in vitro or to assess endothelium function in mice after intravenous
injection. MS patients had increased circulating levels of microparticles compared
with healthy patients, including microparticles from platelet, endothelial,
erythrocyte, and procoagulant origins. In vitro treatment of endothelial cells with
microparticles from MS patients reduced both nitric oxide (NO) and superoxide
anion production, resulting in protein tyrosine nitration. These effects were
associated with enhanced phosphorylation of endothelial NO synthase at the site of
inhibition. The reduction of O2− was linked to both reduced expression of p47phox
of NADPH oxidase and overexpression of extracellular superoxide dismutase. The
decrease in NO production was triggered by nonplatelet-derived microparticles. In
vivo injection of MS microparticles into mice impaired endothelium-dependent
relaxation and decreased endothelial NO synthase expression. These data provide
evidence that circulating microparticles from MS patients influence endothelial
dysfunction.
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